Notable Highlights

Domestic and regional players hold nearly 60-70% share in the bacillus coagulans market. Investment in the research and development activities and expansion of existing R&D facilities to launch new products remains a key strategy of domestic and regional players.

Read Report Overview:

https://www.factmr.com/report/2903/bacillus-coagulans-market

In contrast, leading players in the bacillus coagulans market are focusing on expanding their manufacturing facilities in Asia. These players are also focusing on entering into a strategic partnership with regional distributors and suppliers. Some of the notable developments in the bacillus coagulans market include,

• Ganeden, a US-based probiotic ingredient manufacturer, was recently acquired by Kerry Group. As a result of the acquisition, Ganeden technologies will be extended into wider application across Kerry’s developed and developing markets.
• Sabinsa Corp. has opened its new office in Toronto, expanding its presence in Canada. The company has around 30 natural products approved by Health Canada. The new office will facilitate Canadian importers to comply with Canadian regulations.

Get Report Sample:

https://www.factmr.com/connectus/sample?flag=S&rep_id=2903

• Mitsubishi Chemical and JD.Com have entered into a partnership to launch the largest “plant factory” in China based on hydroponic technology. The factory is nearly 11,040 square meters. The factory produces red and green lettuce, spinach, cabbage, coriander, and other vegetables. The factory is able to produce more vegetables compared to the conventional system.
• UAS Laboratories has announced the acquisition of Nebraska Cultures Inc. Through the acquisition, UAS has exclusivity over Lactobacillus Acidophilus DDS-1 and ProDURA brand.
• Throne entered into a joint strategic investment with Kirin Holdings Company and Mitsui & Co. Ltd. This strategic investment will help Throne to expand its personalized health products and technology platform and grow their businesses in Asia.

The report provides a competition scenario and updated information on the leading players. Some of the major players in bacillus coagulans are Mitsubishi Chemical Foods Corporation, Ganeden, Nebraska Cultures, UAS Laboratories, Sabinsa Corporation, Syngen Biotech, Sanzyme, Microbax, Mystical Biotech Pvt. Ltd, Thorne, Aumgene Bioscience, and other key players.

Get the Discount on the Report:

https://www.factmr.com/connectus/sample?flag=D&rep_id=2903

Increasing Burden of Chronic Digestive Diseases Worldwide

Changing lifestyle and diet is leading to a rise in chronic digestive diseases across the globe. New clinical studies and research have found that bacillus coagulans help to promote digestive health and encourage a healthy immune system. Nearly 20% of people who take antibiotics suffer from antibiotic-associated diarrhoea, and bacillus coagulans have found to be an effective remedy.

Positive effects of bacillus coagulans in serious digestive disorders is resulting in increased consumption of fortified foods and beverages. Several foods and beverages companies are adding bacillus coagulans to their products, targeting a large number of people suffering from digestive disorders.

About Us

We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.

Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.

Our mission is empowerment – empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.

Contact Us

Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Mail: sales@factmr.com
Read Blog: https://theheraldmedia.com/